Lumibird SA
PAR:LBIRD

Watchlist Manager
Lumibird SA Logo
Lumibird SA
PAR:LBIRD
Watchlist
Price: 7.3 EUR Market Closed
Market Cap: 160.6m EUR
Have any thoughts about
Lumibird SA?
Write Note

Lumibird SA
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lumibird SA
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Lumibird SA
PAR:LBIRD
Capital Expenditures
-€25.6m
CAGR 3-Years
-27%
CAGR 5-Years
-18%
CAGR 10-Years
-20%
Ses Imagotag SA
PAR:SESL
Capital Expenditures
-€82.4m
CAGR 3-Years
-22%
CAGR 5-Years
-45%
CAGR 10-Years
-28%
Groupe SFPI SA
PAR:SFPI
Capital Expenditures
-€21.2m
CAGR 3-Years
-19%
CAGR 5-Years
-3%
CAGR 10-Years
-68%
Gea Grenobloise Electronique Automatisme SA
PAR:GEA
Capital Expenditures
-€374k
CAGR 3-Years
-36%
CAGR 5-Years
-16%
CAGR 10-Years
-2%
I2S SA
PAR:ALI2S
Capital Expenditures
-€93k
CAGR 3-Years
40%
CAGR 5-Years
28%
CAGR 10-Years
2%
Vusiongroup SA
PAR:VU
Capital Expenditures
-€87.5m
CAGR 3-Years
-39%
CAGR 5-Years
-46%
CAGR 10-Years
-28%
No Stocks Found

Lumibird SA
Glance View

Market Cap
163.7m EUR
Industry
Electrical Equipment

Lumibird SA engages in the design, manufacturing and marketing of lasers. The company is headquartered in Lannion, Bretagne and currently employs 914 full-time employees. The firm offers a range of products, including compact pulsed Nd, double-pulse Nd, tunable laser systems, flash-lamp pumped lasers, diode-pumped solid-state lasers, semiconductor laser modules and intense pulsed light instruments, among others. Lumibird provides lasers to industrial and scientific clients, as well as the medical sector, among others. The firm operates worldwide through the subsidiaries, such as Quantel Medical, which specializes in the development and marketing of diagnostic ocular ultrasound systems and surgical lasers; Quantel USA, which designs and produces fiber lasers, glass laser systems and tunable lasers, and Quantel Derma AT, which focuses on the development, production and sales of the laser technology products in the areas of dermatology and aesthetics.

LBIRD Intrinsic Value
17.05 EUR
Undervaluation 57%
Intrinsic Value
Price

See Also

What is Lumibird SA's Capital Expenditures?
Capital Expenditures
-25.6m EUR

Based on the financial report for Dec 31, 2023, Lumibird SA's Capital Expenditures amounts to -25.6m EUR.

What is Lumibird SA's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-20%

Over the last year, the Capital Expenditures growth was 13%. The average annual Capital Expenditures growth rates for Lumibird SA have been -27% over the past three years , -18% over the past five years , and -20% over the past ten years .

Back to Top